Pharmacopeias have a well-established history to help protect and improve the health of people around the world through public standards and related programs that help ensure the quality, safety, and benefit of medicines. This mission is shared by many stakeholders to the pharmacopeias, including regulatory agencies and the bio/pharmaceutical industry. There are several examples of collaborative responses to address issues relating to the quality of medicines, including control of contamination in glycerin, heparin, and – more recently – nitrosamines in “sartans”.
The global COVID-19 pandemic has challenged traditional approaches to nearly every aspect of life, including the manufacture, delivery, and development of new and existing medicines. The 2020 PDA Pharmacopeia Conference will explore the intersection of global pharmacopeias, regulators, and industry in responding to such crises. Join us virtually to discuss the roles of the pharmacopeias and various stakeholders in maintaining the drug supply, developing new treatments, and explore lessons learned to help address future health crises appropriately.